Cellulase-Based Colchicine Synthesis with Safer Methylation

The patent replaces expensive, highly purified enzymes with inexpensive, crude cellulase enzymes from filamentous fungi. The cellulase preparation is obtained by simple filtration and centrifugation, eliminating the need for complex purification procedures. This approach uses cheaper, less stable enzymes that are sufficient for the application, accepting their shorter operational lifespan in exchange for dramatically reduced costs and simpler processing.

The patent changes the enzyme source from purified β-glucosidase to crude cellulase preparations from filamentous fungi. This parameter change in enzyme type and origin fundamentally alters the process economics, reducing enzyme costs by orders of magnitude while maintaining acceptable conversion efficiency. The crude enzyme preparations are applied directly without purification, changing the processing parameters to favor industrial scalability.

The patent converts the harmful effects of traditional alkylating agents into beneficial outcomes by using alternative reagents that are safer but equally effective. Instead of using toxic diazomethane, methyl iodide, or dimethylsulphate, the patent employs methyl triflate in a controlled manner or alternative methylating agents that eliminate the need for specialized gas handling equipment and reduce safety hazards while maintaining methylation efficiency.

The patent introduces an intermediary approach by using methyl triflate as a controlled intermediate reagent that provides the necessary methylation functionality with improved safety characteristics. This intermediary reagent acts as a bridge between the substrate and the desired methylated product, offering a safer alternative to traditional alkylating agents while maintaining reaction efficiency.